D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 82 Citations 27,107 175 World Ranking 571 National Ranking 341
Medicine D-index 103 Citations 43,753 393 World Ranking 3226 National Ranking 1854

Research.com Recognitions

Awards & Achievements

1997 - Fellow of the American Academy of Arts and Sciences

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Internal medicine
  • Disease

Stephen L. Hauser mostly deals with Multiple sclerosis, Immunology, Genetics, Allele and Internal medicine. His work carried out in the field of Multiple sclerosis brings together such families of science as Central nervous system disease, Surgery, Disease, Pathology and Myelin. His Disease research includes themes of Pathogenesis, Immune system, Natural history, Neuroscience and Pediatrics.

His Immunology study frequently draws connections between related disciplines such as Myelin basic protein. His Allele research focuses on subjects like Locus, which are linked to Genetic admixture and Age of onset. The concepts of his Internal medicine study are interwoven with issues in Placebo and Ocrelizumab.

His most cited work include:

  • Harrison's Principles of Internal Medicine (12175 citations)
  • Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis (1970 citations)
  • B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. (1745 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Multiple sclerosis, Immunology, Genetics, Internal medicine and Ocrelizumab. His biological study deals with issues like Genetic association, which deal with fields such as Genome-wide association study. His work in Immune system, T cell, Antigen, Antibody and Encephalomyelitis are all subfields of Immunology research.

His biological study spans a wide range of topics, including Gastroenterology, Endocrinology, Surgery and Oncology. His work deals with themes such as Disability progression, Opera and Placebo, which intersect with Ocrelizumab. His Allele research integrates issues from Human leukocyte antigen, Major histocompatibility complex and Genotype.

He most often published in these fields:

  • Multiple sclerosis (51.18%)
  • Immunology (25.59%)
  • Genetics (20.20%)

What were the highlights of his more recent work (between 2017-2021)?

  • Multiple sclerosis (51.18%)
  • Internal medicine (18.35%)
  • Ocrelizumab (11.11%)

In recent papers he was focusing on the following fields of study:

Stephen L. Hauser mainly investigates Multiple sclerosis, Internal medicine, Ocrelizumab, In patient and Neutrino. His Multiple sclerosis research is classified as research in Immunology. He frequently studies issues relating to Central nervous system and Immunology.

His Internal medicine study combines topics in areas such as Gastroenterology, Oncology and Cardiology. His work in Ocrelizumab tackles topics such as Disability progression which are related to areas like Relapse rate. His Neutrino research includes elements of Universe, Astronomy and Astrophysics.

Between 2017 and 2021, his most popular works were:

  • B-cell Therapy for Multiple Sclerosis: Entering an era. (92 citations)
  • Rituximab before and during pregnancy: A systematic review, and a case series in MS and NMOSD. (83 citations)
  • Silent progression in disease activity-free relapsing multiple sclerosis. (81 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Internal medicine
  • Disease

Multiple sclerosis, Internal medicine, Ocrelizumab, Expanded Disability Status Scale and Immunology are his primary areas of study. His Multiple sclerosis study integrates concerns from other disciplines, such as Cohort study, B cell, Disability progression, Magnetic resonance imaging and Disease. His work on Early disease as part of general Disease study is frequently linked to Effective management, therefore connecting diverse disciplines of science.

Stephen L. Hauser has included themes like Genome-wide association study and Oncology in his Internal medicine study. His Ocrelizumab study combines topics from a wide range of disciplines, such as Gastroenterology, Placebo, Randomized controlled trial and Interferon beta-1a. The Immunology study combines topics in areas such as Central nervous system, Allele and Risk factor.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Harrison's Principles of Internal Medicine

Dennis L Kasper;Tinsley Randolph Harrison;Stephen L. Hauser;J. Larry Jameson.
(1950)

12280 Citations

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

Stephen Sawcer;Garrett Hellenthal;Matti Pirinen;Chris C. A. Spencer.
Nature (2011)

2262 Citations

Risk alleles for multiple sclerosis identified by a genomewide study.

David A. Hafler;Alastair Compston;Stephen Sawcer;Mark J. Daly.
The New England Journal of Medicine (2007)

2231 Citations

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.

Stephen L. Hauser;Emmanuelle Waubant;Douglas L. Arnold;Timothy Vollmer.
The New England Journal of Medicine (2008)

2228 Citations

Sequential vs Concurrent Chemoradiation for Stage III Non–Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410

Walter J. Curran;Rebecca Paulus;Corey J. Langer;Ritsuko Komaki.
Journal of the National Cancer Institute (2011)

1073 Citations

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

Xavier Montalban;Stephen L. Hauser;Ludwig Kappos;Douglas L. Arnold.
The New England Journal of Medicine (2017)

1032 Citations

Identification of autoantibodies associated with myelin damage in multiple sclerosis

Claude P. Genain;Barbara Cannella;Stephen L. Hauser;Cedric S. Raine.
Nature Medicine (1999)

1030 Citations

Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

Hauser Sl;Dawson Dm;Lehrich;Beal Mf.
The New England Journal of Medicine (1983)

955 Citations

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.

Stephen L. Hauser;Amit Bar-Or;Giancarlo Comi;Gavin Giovannoni.
The New England Journal of Medicine (2017)

917 Citations

The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration.

Stephen L. Hauser;Jorge R. Oksenberg.
Neuron (2006)

881 Citations

Best Scientists Citing Stephen L. Hauser

Xavier Montalban

Xavier Montalban

Autonomous University of Barcelona

Publications: 164

David A. Hafler

David A. Hafler

Yale University

Publications: 150

Howard L. Weiner

Howard L. Weiner

Harvard University

Publications: 148

Jan Hillert

Jan Hillert

Karolinska Institute

Publications: 127

Gavin Giovannoni

Gavin Giovannoni

Queen Mary University of London

Publications: 123

George C. Ebers

George C. Ebers

University of Oxford

Publications: 121

Hans Lassmann

Hans Lassmann

Medical University of Vienna

Publications: 120

Philip L. De Jager

Philip L. De Jager

Columbia University

Publications: 119

Tomas Olsson

Tomas Olsson

Karolinska Institute

Publications: 117

Hans-Peter Hartung

Hans-Peter Hartung

Heinrich Heine University Düsseldorf

Publications: 115

Roland Martin

Roland Martin

University of Zurich

Publications: 108

Frederik Barkhof

Frederik Barkhof

University College London

Publications: 106

Friedemann Paul

Friedemann Paul

Max Delbrück Center for Molecular Medicine

Publications: 106

Ludwig Kappos

Ludwig Kappos

University Hospital of Basel

Publications: 103

Bernhard Hemmer

Bernhard Hemmer

Technical University of Munich

Publications: 101

Peter A. Calabresi

Peter A. Calabresi

Johns Hopkins University School of Medicine

Publications: 101

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us
Something went wrong. Please try again later.